NL
VIR icon

NVWM LLC’s Vir Biotechnology VIR Stock Holding History

NVWM LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.9K Buy
1,240
+1,100
+786% +$11K ﹤0.01% 356
2026
Q2 		$1.43K Buy
140
+40
+40% +$381 ﹤0.01% 565
2026
Q1 		$896 Buy
+100
New +$797 ﹤0.01% 589
2023
Q3 		– Sell
-29,847
Closed -$732K – 482
2023
Q2 		$732K Buy
29,847
+6,050
+25% +$152K 0.24% 134
2023
Q1 		$554K Buy
+23,797
New +$609K 0.19% 153

Other funds holding VIR

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Foster Group
Foster Group West Des Moines, Iowa $3.68B AUM 13.84% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FIA
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

NVWM LLC's VIR Position: Q3 2026 in Review

NVWM LLC increased its Vir Biotechnology (VIR) stake by 786% in Q3 2026, buying an estimated $11K and bringing the position to 1,240 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

NVWM LLC first reported a position in VIR in Q1 2023 and has held it in 5 quarters since. The position peaked at $732K in Q2 2023. 21 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • NVWM LLC held 1,240 shares of Vir Biotechnology worth $13.9K as of Q3 2026.
  • NVWM LLC bought 1,100 Vir Biotechnology shares in Q3 2026, an estimated $11K.
  • Vir Biotechnology made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #356 holding.
  • NVWM LLC first reported a position in Vir Biotechnology in Q1 2023 and has held it in 5 quarters since.
  • NVWM LLC's Vir Biotechnology position peaked at $732K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.